Trials / Conditions / Actinic Keratosis (AK)

Actinic Keratosis (AK)

10 registered clinical trials studyying Actinic Keratosis (AK) — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients NCT07286318	Marissa Lobl	EARLY_Phase 1
Recruiting	Evaluate RLS-1496 Topical Cream for Actinic Keratosis NCT07340697	Rubedo Life Sciences, Inc.	Phase 1 / Phase 2
Recruiting	A Phase Ib Study of HW211026 Ointment in Patients With Actinic Keratosis. NCT07318675	Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.	Phase 1
Recruiting	Study of the Photoprotection and Prevention of Actinic Damage With Anthelios Fluide 100 KA+ UVMune 400 in Pati NCT07335003	Cosmetique Active International	N/A
Completed	Indoor Daylight Photodynamic Therapy is an Effective, First-line Treatment for AK, But Its Feasibility is Limi NCT07290959	San Salvatore Hospital of L'Aquila	N/A
Recruiting	Investigation of the Efficacy and Tolerability of Topical Applied Tirbanibulin on Actinic Keratoses With Downw NCT06648447	Thomas Dirschka	—
Completed	Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) Cream NCT03727074	Sol-Gel Technologies, Ltd.	Phase 3
Completed	A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face an NCT03116698	Dr. Reddy's Laboratories Limited	Phase 2 / Phase 3
Completed	Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actin NCT02406014	LEO Pharma	Phase 4
Completed	Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5 NCT01926496	LEO Pharma	Phase 4